Xpress Biologics now part of Sartorius

Xpress Biologics, Polyplus compagny and now part of Sartorius, is a biotech company proposing contract services for the production of recombinant proteins, antibody fragments and plasmid DNA for preclinical applications (therapeutic and diagnostic markets). The production scale goes from 100 mg up to 10 g with, depending of the use of the biologics, R&D and GLP qualities. The production processes proposed by Xpress Biologics are all developed in microbial expression system, E. coli (soluble cytoplasmic, inclusion bodies and periplasmic productions) and P. pastoris (secreted protein) mainly. These processes are IP free and take into account the regulatory and industrial (scale-up)...

Protein production,antibody fragment production,plasmid dna production,contract service,microbial fermentation,glp manufacturing,diagnostic,pre-clinical applications,and gmp

Xpress biologics now part of sartorius operates in the Biotechnology research industry.

Xpress biologics now part of sartorius's revenue is 11m - 100m

Xpress biologics now part of sartorius has 51 - 200 employees.